focus -WSS

focus

author：entertainment 2025-09-29 21:28:05 - browse：71

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Advances in CAR

explore

focus

WSS

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

The new HIV moral panic

What drug price negotiations mean for Medicare Part D

The (many) problems with a new study criticizing cancer screening

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

How to protect patients from sexual assault

focus

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

How to protect patients from sexual assault

United colonoscopy coverage change 'may cost lives,' doctors say

Congress likely to miss an opportunity to fix drug shortages issue

In Memoriam: Notable people who died in 2023

How to fix cancer clinical trials' diversity problem

Medical leaders decry Supreme Court decision on affirmative action

Amazon on where the company's health care bets are headed next

As demand for Covid shots wanes, Moderna seeks its next success

Who gets to use the title 'doctor'?

leisure time

Trump surgeon general acknowledges mistakes during Covid

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

J&J expands global access to TB drug amid advocacy campaign

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Medicaid rebukes states for mistakenly disenrolling children

explore

focus

knowledge

hotspot